Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.00 | $0.11 | $0.05 |
| Q2 2026 | 1 | $0.18 | $0.19 | $0.19 |
| Q3 2026 | 1 | $0.29 | $0.30 | $0.29 |
| Q4 2026 | 1 | $0.42 | $0.44 | $0.43 |
| Q1 2027 | 1 | $0.19 | $0.20 | $0.20 |
| Q2 2027 | 1 | $0.25 | $0.26 | $0.25 |
| Q3 2027 | 1 | $0.30 | $0.31 | $0.30 |
| Q4 2027 | 1 | $0.52 | $0.54 | $0.53 |
AdaptHealth Corp last posted its earnings results on Tuesday, November 4th, 2025. The company reported $0.22 earnings per share for the quarter, missing analysts' consensus estimates of $0.24 by $0.02. The company had revenue of 820.31 M for the quarter and had revenue of 3.26 B for the year. AdaptHealth Corp has generated $1 earnings per share over the last year ($0.61 diluted earnings per share) and currently has a price-to-earnings ratio of 16.96. AdaptHealth Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2025 | Q3 2025 | $0.24 | $0.17 | -0.07 | $799.31 M | $820.31 M |
| 08/05/2025 | Q2 2025 | $0.15 | $0.10 | -0.05 | $803.80 M | $591.81 M |
| 05/06/2025 | Q1 2025 | $0.01 | -$0.05 | -0.06 | N/A | $580.47 M |
| 02/25/2025 | Q4 2024 | $0.25 | $0.34 | 0.09 | N/A | $856.65 M |
| 11/05/2024 | Q3 2024 | $0.17 | $0.16 | -0.01 | $809.32 M | $597.55 M |
| 08/06/2024 | Q2 2024 | $0.19 | $0.13 | -0.06 | $802.62 M | $595.03 M |
| 05/07/2024 | Q1 2024 | $0.06 | -$0.02 | -0.08 | N/A | $594.10 M |
| 02/27/2024 | Q4 2023 | $0.20 | -$1.91 | -2.11 | N/A | $1.48 B |
| 11/07/2023 | Q3 2023 | $0.19 | -$3.37 | -3.56 | N/A | $583.68 M |
| 08/08/2023 | Q2 2023 | $0.11 | $0.10 | -0.01 | N/A | $583.62 M |
| 05/09/2023 | Q1 2023 | $0.08 | $0.11 | 0.03 | N/A | $744.63 M |
| 02/28/2023 | Q4 2022 | N/A | -$0.02 | N/A | N/A | $1.36 B |
| 11/08/2022 | Q3 2022 | $0.31 | $0.11 | -0.2 | N/A | $557.65 M |
| 08/09/2022 | Q2 2022 | $0.28 | $0.10 | -0.18 | N/A | $531.28 M |
| 05/10/2022 | Q1 2022 | $0.21 | $0.29 | 0.08 | N/A | $524.55 M |
| 03/01/2022 | Q4 2021 | N/A | $0.16 | N/A | N/A | $702.11 M |
| 11/09/2021 | Q3 2021 | N/A | $0.40 | N/A | N/A | $472.78 M |
| 08/06/2021 | Q2 2021 | N/A | $0.56 | N/A | N/A | $617.02 M |
| 05/10/2021 | Q1 2021 | N/A | -$0.04 | N/A | N/A | $482.12 M |
| 03/16/2021 | Q4 2020 | N/A | -$0.47 | N/A | N/A | $348.43 M |
The conference call for AdaptHealth Corp's latest earnings report can be listened to online.
The conference call transcript for AdaptHealth Corp's latest earnings report can be read online.
AdaptHealth Corp (:AHCO) has a recorded annual revenue of $3.26 B.
AdaptHealth Corp (:AHCO) has a recorded net income of $90.42 M.AdaptHealth Corp has generated $0.62 earnings per share over the last four quarters.
AdaptHealth Corp (:AHCO) has a price-to-earnings ratio of 16.96 and price/earnings-to-growth ratio is 9.33.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED